<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000044940">
  <TermName>MS 209</TermName>
  <TermDefinition>
    <DefinitionText>A substance that is being studied for its ability to make cancer cells respond better to chemotherapy drugs to which they have become resistant. It is a type of quinolone antibiotic.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>MS 209</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio por su capacidad para hacer que las células cancerosas respondan mejor a los medicamentos quimioterapéuticos a los que se volvieron resistentes. Es un tipo de antibiótico de quinolona.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2008-07-22</DateLastModified>
</GlossaryTerm>
